Anbc, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SYUP research report →
Companywww.anbc.com
Shanghai Yutong Pharma, Inc. engages in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals in the People's Republic of China. Its products primarily include Qilisheng a product formulated to be a general health enhancer by fortifying the immune system; Qi-ju-di-huang, an oral solution that protects the kidney and the liver; Qing-re-jie-du, an oral solution that reduces fever and relieves heat; Sheng-mai-yin, a solution that protects energy and enhances body fluids; Xiao-qing-long, an oral solution that relieves cough and dyspnea; Shen-bao, a syrup for the treatment of impotence and spermatorrhoea; Ban-xia, a syrup that relieves cough; and Gan-mao-zhi-ke, a syrup that relieves flu symptoms, cough, and nasal congestion.
- CEO
- Wei Dong
- IPO
- 2009
- HQ
- Shanghai, CN
Price Chart
Valuation
- Market Cap
- $15.92K
- P/E
- 0.01
- P/S
- 0.01
- P/B
- 0.01
- EV/EBITDA
- -0.04
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 49.12%
- Op Margin
- 42.83%
- Net Margin
- 41.14%
- ROE
- 85.99%
- ROIC
- 70.39%
Growth & Income
- Revenue
- $3.16M · 10.03%
- Net Income
- $1.30M · 7.15%
- EPS
- $0.02 · -70.94%
- Op Income
- $1.35M
- FCF YoY
- 12034.96%
Performance & Tape
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -6.12
- Avg Volume
- 54.59K
Get TickerSpark's AI analysis on SYUP
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SYUP Coverage
We haven't published any research on SYUP yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SYUP Report →